GSTM3 Knockdown Promotes Liver Fibrosis Reversal by Inhibiting Hepatic Stellate Cell Activation via PPARγ Signaling
Journal of Clinical and Translational Hepatology · 25.05.2026 · 000 (000) · 000-000
DOI: 10.14218/jcth.2025.00658 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Translational Hepatology, online erschienen am 25.05.2026. Verfasst von Chenxue Hou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
- Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Zitieren
APA
Hou, C., Yang, B., Zhao, Y., Chang, H., Bu, T., Wang, Q., & Li, Y. (2026). GSTM3 Knockdown Promotes Liver Fibrosis Reversal by Inhibiting Hepatic Stellate Cell Activation via PPARγ Signaling. Journal of Clinical and Translational Hepatology, 000(000), 000-000. https://doi.org/10.14218/jcth.2025.00658
Vancouver
Hou C, Yang B, Zhao Y, Chang H, Bu T, Wang Q, et al. GSTM3 Knockdown Promotes Liver Fibrosis Reversal by Inhibiting Hepatic Stellate Cell Activation via PPARγ Signaling. Journal of Clinical and Translational Hepatology. 2026;000(000):000-000. doi:10.14218/jcth.2025.00658
BibTeX
@article{Hou2026,
author = {Hou, Chenxue and Yang, Bingqing and Zhao, Yuanying and Chang, Hao and Bu, Tong and Wang, Qi and Li, Yue},
title = {GSTM3 Knockdown Promotes Liver Fibrosis Reversal by Inhibiting Hepatic Stellate Cell Activation via PPARγ Signaling},
journal = {Journal of Clinical and Translational Hepatology},
year = {2026},
volume = {000},
number = {000},
pages = {000--000},
doi = {10.14218/jcth.2025.00658}
}
EUVIMED